Literature DB >> 29095694

Visual assessment of hemolysis affects patient safety.

Ana Helena Luksic1, Nora Nikolac Gabaj2, Marijana Miler2, Lora Dukic3, Ana Bakliza4, Ana-Maria Simundic3.   

Abstract

BACKGROUND: Manual handling of hemolyzed samples is not standardized and is vulnerable to errors. This study aimed to evaluate laboratory errors due to manual handling of hemolyzed samples and to assess the risk they might have for patient safety.
METHODS: Data were retrospectively obtained from a laboratory information system for 25 emergency tests from hemolyzed samples. Hemolysis (concentration of free hemoglobin >0.5 g/L) was visually assessed by comparison with a color chart. The reference person reestimated the routinely assessed degree of hemolysis to all samples (n=3185) received in the laboratory in a 1-week period. For each test, the correct and incorrect way of handling results was determined. Risk assessment was performed according to ISO 14971 standard with five categories of risk (S1-S5) and error occurrence (O1-O5).
RESULTS: In the studied period, the emergency laboratory received 495 hemolyzed samples (15.5%) with a total of 2518 laboratory test requests (15.5%): 102 (20.6%) of the reports from hemolyzed samples had a comment on hemolysis; 31% of the test results were handled incorrectly (20.7% due to the incorrect release of the test result despite hemolysis interference and 10.3% due to unnecessary suppression), accounting for 4.8% of the total test volume. Tests with the highest combination of risk and occurrence rate were troponin T, potassium and total bilirubin.
CONCLUSIONS: Manual handling of hemolyzed samples may lead to risk of errors in reporting results for troponin T, potassium and total bilirubin, which may have an effect on clinical decision. In addition, unnecessary suppression of the sample results unaffected by hemolysis could affect patient outcome.

Entities:  

Keywords:  hemolysis; patient safety; risk assessment; visual assessment of hemolysis

Mesh:

Year:  2018        PMID: 29095694     DOI: 10.1515/cclm-2017-0532

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Interferograms plotted with reference change value (RCV) may facilitate the management of hemolyzed samples.

Authors:  Kamil Taha Uçar; Abdulkadir Çat; Alper Gümüş; Nilhan Nurlu
Journal:  J Med Biochem       Date:  2022-02-02       Impact factor: 3.402

2.  Hemolysis Interference Studies: The Particular Case of Sodium Ion.

Authors:  José Antonio Delgado; Daniel Morell-Garcia; Josep Miquel Bauça
Journal:  EJIFCC       Date:  2019-03-01

3.  Determination of hemolysis index thresholds for biochemical tests on Siemens Advia 2400 chemistry analyzer.

Authors:  Zhenhua Du; JiQin Liu; Hua Zhang; BuHe Bao; RuiQi Zhao; Ying Jin
Journal:  J Clin Lab Anal       Date:  2019-02-19       Impact factor: 2.352

4.  A Reference chart for clinical biochemical tests of hemolyzed serum samples.

Authors:  Jun Ni; Wenbo Zhu; Yanyang Wang; Xuefei Wei; Jingjing Li; Lu Peng; Kui Zhang; Bing Bai
Journal:  J Clin Lab Anal       Date:  2020-09-02       Impact factor: 2.352

5.  Impact of Individualized Hemolysis Management Based on Biological Variation Cut-offs in a Clinical Laboratory.

Authors:  Fernando Marques-Garcia; David Hansoe Heredero Jung; Sandra Elena Pérez
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

6.  Measuring haemolysis in cattle serum by direct UV-VIS and RGB digital image-based methods.

Authors:  Belén Larrán; Marta López-Alonso; Marta Miranda; Víctor Pereira; Lucas Rigueira; María Luisa Suárez; Carlos Herrero-Latorre
Journal:  Sci Rep       Date:  2022-08-08       Impact factor: 4.996

7.  Hemolytic specimens in complete blood cell count: Red cell parameters could be revised by plasma free hemoglobin.

Authors:  Zhaoyang Peng; Wenqing Xiang; Jianming Zhou; Jiajia Cao; Zhe Li; Hui Gao; Junfeng Zhang; Hongqiang Shen
Journal:  J Clin Lab Anal       Date:  2020-01-22       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.